Martin Colombatto - Jun 4, 2021 Form 4 Insider Report for Ra Medical Systems, Inc. (RMED)

Role
Director
Signature
/s/ Daniel Horwood, as Attorney-in-Fact
Stock symbol
RMED
Transactions as of
Jun 4, 2021
Transactions value $
$0
Form type
4
Date filed
6/8/2021, 08:00 PM
Next filing
Jan 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMED Common Stock Award $0 +4K +15.72% $0.00 29.4K Jun 4, 2021 Direct F1
holding RMED Common Stock 1.5K Jun 4, 2021 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service.
F2 Shares held of record by the M Colombatto Trust, for which the reporting person serves as trustee.